[Cell surface adhesion molecules: structure, function, clinical aspects].

Z Szekanecz; G Szegedi

Home/Archive/PubMed

PubMed · 1310354

[Cell surface adhesion molecules: structure, function, clinical aspects].

Z Szekanecz·G Szegedi

View original source ↗Export metadata ↓

Abstract

Intercellular and cell-matrix interactions play a crucial role in several physiological and pathological processes. These relationships are based on different cell adhesion molecules. Although adhesion receptors exhibit structural diversity, cell adhesion mechanisms are basically similar to each other. Details of receptor functions (e.g. the exact mechanisms of signal transduction) is poorly understood. In this paper authors summarize data on different cell adhesion antigens and also describe a few important biological features to collect more data on the complex interactions of these molecules.

Explore related subjects

Cell Adhesion Molecules Cell Differentiation Humans Integrins Membrane Proteins Receptors, Cell Surface Receptors, Cytoadhesin English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Z Szekanecz, G Szegedi. 1992-01-19. [Cell surface adhesion molecules: structure, function, clinical aspects].. https://pubmed.ncbi.nlm.nih.gov/1310354/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

The assembly of laminin-5 subunits.

Laminin-5 is a heterotrimer composed of alpha 3, beta 3, and gamma 2 chains, produced by keratinocytes and the human squamous cell carcinoma line (SCC-25), and is one of the candidate proteins for the genetic lesion in junctional epidermolysis bullosa. Two-dimensional SDS-polyacrylamide gel electrophoresis (first dimension, nonreducing conditions; second dimension, reducing conditions) revealed that the immunoprecipitated laminin-5 from a SCC-25 cell fraction consisted of alpha 3, beta 3, and gamma 2 monomers, a beta 3 gamma 2 heterodimer, and an alpha 3 beta 3 gamma 2 heterotrimer. The presence of the beta 3 gamma 2 heterodimer, but not heterodimers containing an alpha 3 chain and any of the other chains, was suggestive of assembly of laminin-5 proceeding from a beta 3 gamma 2 heterodimer to an alpha 3 beta 3 gamma 2 heterotrimer. We showed, by cotransfection experiments using full-length recombinant beta 3 and gamma 2 chains in a human cell line devoid of endogenous laminin-5, that stable heterodimers can be formed in the absence of alpha 3 chain expression. In the SCC-25 cell fraction, the alpha 3 monomer pool was the smallest of the monomers. Pulse-chase experiments using the cell fraction also indicated that the heterotrimer was assembled after a 10-min pulse and was nearly absent after a 24-h chase. These results are consistent with the synthesis of alpha 3 being limiting for heterotrimer assembly, with rapid association of the alpha 3 chain with beta 3 gamma 2 heterodimers to form complete heterotrimers. Treatment with tunicamycin reduced the size of each of the laminin-5 subunits, indicating that all chains are glycosylated, but that N-linked glycosylation is not necessary for chain assembly and secretion.

Cell Adhesion Molecules↗

PubMed1995

[Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].

The RGD (Arg-Gly-Asp) motif has a widespread distribution in the cellular adhesive structures on platelets, lymphocytes, some viruses and matrix proteins. RGD sequence seems to confer adhesive properties to macromolecular proteins like fibronectin, vitronectin, von Willebrand factor, fibrinogen and many others. So RGD tripeptide and its analogues really deserve to be regarded as general disintegrin sequence. A concise review is given to analyze the most important achievements by using RGD peptides as antiplatelet agents along with an overview of the potential clinical application of the disintegrin peptides in other fields of medicine.

Cell Adhesion Molecules↗

PubMed1995

Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha.

We have investigated the role of the two distinct tumor necrosis factor (TNF) receptors (TNFR60 and TNFR80) in endothelial cell activation employing an in vitro model of tumor necrosis factor alpha (TNF-alpha)-dependent tissue factor production of human umbilical vein endothelial cells (HUVECs). In this model, tissue factor is produced either on addition of exogeneous TNF-alpha, or by induction of endogenous TNF-alpha via adhesion molecule-linked signal pathways. Under both conditions, tissue factor expression could be partially blocked by antagonistic antibodies against either TNFR60 or TNFR80 and was fully inhibited by simultaneous application of both antibodies. Selective inhibitors of either TNFR60 or TNFR80-induced signal pathways inhibited tissue factor expression, and selective triggering of either of the two TNF receptors by agonistic antibodies induced this response in HUVECs. Furthermore, a coculture system of HUVECs and Chinese hamster ovary transfectants expressing a noncleavable, exclusively membrane-bound form of TNF-alpha resulted in a potent activation of HUVECs with synergistic action of both TNF receptors. Together, these data underline the importance of juxtacrine pathways in endothelial cell activation of procoagulant functions and show that membrane TNF-alpha and both TNFR types play a critical role.

Cell Adhesion Molecules↗